Features include Headlines, Commentaries, Conference Coverage and Videos.
Browsing: Features
ASCO 2020: Trial validates a less intense treatment for HPV positive throat cancer
The final results of the randomised phase two trial E3311 will be presented at the…
ASCO 2020: Apalutamide significantly improved overall survival in patients with non-metastatic castration-resistant prostate cancer
It has been announced that the results from the final analysis of the pivotal Phase…
ASCO 2020: Videoconference intervention significantly reduces anxiety and distress among remote caregivers of people with cancer
“As COVID-19 forces separation from loved ones and increases anxiety for people with cancer and…
ASCO 2020: Maintenance therapy With PARP inhibitor olaparib extends survival by over 1 year in patients with relapsed ovarian cancer and BRCA mutation
Maintenance therapy with olaparib extended overall survival by nearly 13 months (12.9) compared with placebo…
Developing microbeam radiation therapy (MRT) for inoperable cancer
An innovative radiation treatment that could one day be a valuable addition to conventional radiation…
Children with cancer are not at a higher risk for COVID-19 infection or morbidity
Researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK), USA, found that children…
ASCO 2020: New class of targeted radioactive treatment effective for men with metastatic prostate cancer
The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) reports the interim…
World-first saliva test detects hidden throat cancer
A simple saliva test developed by Queensland University of Technology (QUT) biomedical scientists has detected…
Antihistamines may help patients with malignant melanoma
Can a very common allergy medicine improve survival among patients suffering from the serious skin…
More than 10,000 job losses, billions in lost revenue: coronavirus will hit Australia’s research capacity harder than the GFC
Frank Larkins, University of Melbourne and Kylie Walker, Australian National University Australia’s researchers have answered…